Clinical Observation of Regulating Tri-jiao Catgut Embedding Method in the Treatment of Metabolic Associated Fatty Liver Disease.

Authors
Category Primary study
Registry of TrialsITMCTR
Year 2022
INTERVENTION: treatment group:catgut embedding;control group:exercise and diet duidance; CONDITION: Metabolic Associated Fatty Liver Disease PRIMARY OUTCOME: HDL‐C;BMI;GGT;FINS;LEP;WC;ADP;LSM;AST;FPG;CAP;TG;LDL‐C;BW;TC;ALT; INCLUSION CRITERIA: (1) Western medicine is in line with the diagnosis of metabolic disorder mafld, traditional Chinese medicine is in line with the syndrome of internal stagnation of dampness and turbidity, which is diagnosed by doctors; (2) Patients aged 18‐50 years; (3) No medication or acupuncture catgut embedding related treatment within 3 months; (4) Willing to participate in the experiment of this subject and sign the informed consent form. Note: patients who meet the above four items at the same time can be included in this study.
Epistemonikos ID: b65bd2eb4e2b9aec5ddebd9619f098b9a83f6321
First added on: Aug 26, 2024